Developmental outcome after exposure to cyclooxygenase inhibitors during pregnancy and lactation

Briggs, 1998 Cappon, 2003, Comparison of the developmental toxicity of aspirin in rabbits when administered throughout organogenesis or during sensitive windows of development, Birth Defects Res B Dev Reprod Toxicol, 68, 47, 10.1002/bdrb.10008 Cook, 2003, Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits, Birth Defects Res B Dev Reprod Toxicol, 68, 5, 10.1002/bdrb.10005 Burdan, 2006, Congenital ventricular septal defects and prenatal exposure to cyclooxygenase inhibitors, Braz J Med Biol Res, 39, 925, 10.1590/S0100-879X2006000700011 Burdan, 2006, Celosomy is associated with prenatal exposure to cyclooxygenase inhibitors, Pharmacol Res, 53, 287, 10.1016/j.phrs.2005.12.006 Werler, 2002, Maternal medication use and risks of gastroschisis and small intestinal atresia, Am J Epidemiol, 155, 26, 10.1093/aje/155.1.26 Ostensen, 2004, Anti-inflammatory pharmacotherapy during pregnancy, Expert Opin Pharmacother, 5, 571, 10.1517/14656566.5.3.571 Ofori, 2006, Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case–control study, Birth Defects Res B Dev Reprod Toxicol, 77, 268, 10.1002/bdrb.20085 Ostensen, 2006, Anti-inflammatory and immunosuppressive drugs and reproduction, Arthritis Res Ther, 8, 209, 10.1186/ar1957 Takahashi, 2000, Cyclooxygenase-2 inhibitors constrict the fetal lamb ductus arteriosus both in vitro and in vivo, Am J Physiol: Regul Integr Comp Physiol, 278, R1496 Temprano, 2005, Antirheumatic drugs in pregnancy and lactation, Semin Arthritis Rheum, 35, 112, 10.1016/j.semarthrit.2005.05.002 US Food and Drug Administration, 1994 Claudio, 1999, Assessment of the US Environmental Protection Agency methods for identification hazards to developing organisms. Part II: the developmental toxicity testing guideline, Am J Inter Med, 35, 554, 10.1002/(SICI)1097-0274(199906)35:6<554::AID-AJIM2>3.0.CO;2-X EMEA. Note for guidance on repeated dose toxicity CMP/SWP/1042/99. http://www.emea.eu.int. World Health Organization, 2001, Principles for evaluating health risk to reproduction associated with exposure to chemicals, Environ Health Criteria, 225, 1 PDR, 1998 Pescar, 2002, Interaction of COX-2 inhibitors and salicylate in gastric mucosal damage, Eur J Pharmacol, 434, 65, 10.1016/S0014-2999(01)01524-2 Burdan, 2005, Morphological studies in modern teratological investigations, Folia Morphol (Warsz), 64, 1 Burdan, 2002, A new rapid radiological procedure for routine teratological use in bone ossification assessment: a supplement for staining methods, Teratology, 66, 315, 10.1002/tera.10116 Różyło-Kalinowska, 2003, Optimization of analysis of skeletal ossification of laboratory animals by means of digital radiography software options, Ann Univ Mariae Curie Sklodowska Med, 58, 94 Young, 2000, Large-scale double-staining of rat fetal skeletons using alizarin red S and alcian blue, Teratology, 61, 273, 10.1002/(SICI)1096-9926(200004)61:4<273::AID-TERA5>3.0.CO;2-2 Solecki, 2003, Harmonization of rat fetal external and visceral terminology and classification, Reprod Toxicol, 17, 625, 10.1016/S0890-6238(03)00092-3 Solecki, 2001, Harmonisation of rat fetal skeletal terminology and classification – report of the third workshop on the terminology in developmental toxicology, Reprod Toxicol, 15, 713, 10.1016/S0890-6238(01)00179-4 Christian, 2001, Test methods for assessing female reproductive and developmental toxicology, 1301 Paumgartten, 2009, Harmonization of terminology in developmental toxicology: the quest for a more precise description and a harmonized classification of fetal observations, Reprod Toxicol, 27, 8, 10.1016/j.reprotox.2008.12.001 DevTox. http://www.DevTox.org. Burdan, 2008, Cyclooxygenase inhibitors affect bone mineralisation in rat fetuses, Cells Tissues Organs, 187, 221, 10.1159/000111077 Burdan, 2004, Gastrointestinal and hepatic toxicity of selective and nonselective cyclooxygenase-2 inhibitors in pregnant and nonpregnant rats, Pharmacol Res, 50, 534, 10.1016/j.phrs.2004.04.008 Burdan, 2009, Maternal toxicity of nonsteroidal anti-inflammatory drugs as an important factor affecting prenatal development, Reprod Toxicol, 28, 239, 10.1016/j.reprotox.2009.04.004 Chalas A. [Organ toxicity of selective and non-selective cyclooxygenase-2 inhibitors administered during pregnancy and lactation to Wistar rats] – PhD dissertation medical. Lublin: University of Lublin; 2006 (in Polish). Burdan, 2004, Developmental toxicity evaluation of ibuprofen and tolmetin administered in triple daily doses to Wistar CRL:(WI)WUBR rats, Birth Defects Res B Dev Reprod Toxicol, 71, 321, 10.1002/bdrb.20018 Burdan, 2005, Comparison of developmental toxicity of selective and non-selective cyclooxygenase-2 inhibitors in CRL:(WI)WUBR Wistar rats – DFU and piroxicam study, Toxicology, 211, 12, 10.1016/j.tox.2005.02.005 Manson, 1994, The methods for assessing female reproductive and developmental toxicology, 989 Adams, 1969, Absorption distribution and toxicity of ibuprofen, Toxicol Appl Pharmacol, 15, 310, 10.1016/0041-008X(69)90032-5 Nishimura, 1977, Teratogenicity study of 1-methyl-5-ptoluylopyrrole-2-acetate sodium dihydrate (tolmetin sodium) in rabbits, Iykuhin Kenkyu, 8, 158 Perraud, 1984, Reproductive studies with the anti-inflammatory agent piroxicam: modification classical protocols, Toxicology, 30, 59, 10.1016/0300-483X(84)90062-3 Cappon, 2005, Combined treatment potentiates the developmental toxicity of ibuprofen and acetazolamide in rats, Drug Chem Toxicol, 28, 409, 10.1080/01480540500262805 Burdan, 2003, Prenatal effects of DuP-697 – the irreversible highly selective cyclooxygenase-2 inhibitor, Reprod Toxicol, 17, 413, 10.1016/S0890-6238(03)00045-5 PDR, 2003 Khera, 1981, Common fetal aberration and their teratogenic significance: a review, Fundam Appl Toxicol, 1, 13 Beck, 1990, Prenatal and postnatal assessment of maneb-exposed CD-1 mice, Reprod Toxicol, 4, 283, 10.1016/0890-6238(90)90040-3 Chernoff, 1991, Significance of supernumerary ribs in rodent developmental toxicity studies: postnatal persistence in rats and mice, Fundam Appl Toxicol, 17, 448, 10.1016/0272-0590(91)90196-B Tothill, 2002, Bone mineral and soft tissue measurements by dual-energy X-ray absorptiometry during growth, Bone, 31, 492, 10.1016/S8756-3282(02)00854-2 Zuhlke, 2000, Future trends in primate toxicology and refined techniques, 233 Lee, 2003, Detecting microdamage in bone, J Anat, 203, 161, 10.1046/j.1469-7580.2003.00211.x Chahoud, 2005, Relationship between fetal body weight of Wistar rats at term and the extent of skeletal ossification, Braz J Med Biol Res, 38, 565, 10.1590/S0100-879X2005000400010 Reid, 2002, Relationship among body mass its components and bone, Bone, 31, 547, 10.1016/S8756-3282(02)00864-5 Solecki M. [Tumor necrosis factor gene expression and morphology of epiphyseal cartilage in rats offspring exposed to cyclooxygenase inhibitors] – PhD dissertation. Lublin: Medical University of Lublin; 2007 (in Polish). Zuchnik-Wrona A. [Morphology of the shoulder and elbow joint, and expression of COX-1 and COX-2 genes in the epiphyseal cartilage in rats offsprings exposed to cyclooxygenase inhibitors during pregnancy and lactation] – PhD dissertation. Lublin: Medical University of Lublin; 2011 (in Polish). Clark, 1984, Diflunisal-induced maternal anemia as a cause of teratogenicity in rabbits, Teratology, 30, 319, 10.1002/tera.1420300304 Oster, 2011, Associations between maternal fever and influenza and congenital heart defects, J Pediatr, 158, 905, 10.1016/j.jpeds.2010.11.058